-
341por Bauden, Monika, Pamart, Dorian, Ansari, Daniel, Herzog, Marielle, Eccleston, Mark, Micallef, Jake, Andersson, Bodil, Andersson, Roland“…BACKGROUND: To improve the prognosis of patients with pancreatic cancer, new biomarkers are required for earlier, pre-symptomatic diagnosis. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342por HATTORI, NORIFUMI, YAMADA, SUGURU, TORII, KOJI, TAKEDA, SHIGEOMI, NAKAMURA, KAE, TANAKA, HIROMASA, KAJIYAMA, HIROAKI, KANDA, MITSURO, FUJII, TSUTOMU, NAKAYAMA, GORO, SUGIMOTO, HIROYUKI, KOIKE, MASAHIKO, NOMOTO, SHUJI, FUJIWARA, MICHITAKA, MIZUNO, MASAAKI, HORI, MASARU, KODERA, YASUHIRO“…We explored the indirect effect of NEAPP through plasma-activated medium (PAM) on pancreatic cancer cells in vitro and in vivo. In this study, four pancreatic cancer cell lines were used and the antitumor effects of PAM treatment were evaluated using a cell proliferation assay. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343por Torres, Pedro J., Fletcher, Erin M., Gibbons, Sean M., Bouvet, Michael, Doran, Kelly S., Kelley, Scott T.“…Clinical manifestations of pancreatic cancer often do not occur until the cancer has undergone metastasis, resulting in a very low survival rate. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344“…Despite the rapid progress on the genomics and proteomics of the neoplastic cells, therapies that targeted the pancreatic cancer cells proved to be inefficient, which promoted the researchers to turn their attentions to the microenvironment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
345“…BACKGROUND: We report a case of recurrent pancreatic cancer that presented as cervical lymphadenopathy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
346por Hussain, S. Perwez“…Pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, remains one of the highly lethal malignancies. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
347por Chand, Saswati, O'Hayer, Kevin, Blanco, Fernando F., Winter, Jordan M., Brody, Jonathan R.“…Pancreatic cancer (pancreatic ductal adenocarcinoma, PDA) is infamously moving to the top of the list as one of the most lethal cancers with an overall 5 year survival rate of 7%. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
348“…The genetic landscape of pancreatic cancer shows nearly ubiquitous mutations of K-RAS. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
349por Bhutani, Manoop S., Koduru, Pramoda, Joshi, Virendra, Saxena, Payal, Suzuki, Rei, Irisawa, Atsushi, Yamao, Kenji“…Pancreatic cancer (PC) is a highly lethal cancer. Despite a significant advancement in cancer treatment, the mortality rate of PC is nearly identical to the incidence rates. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
350“…Pancreatic cancer is the most lethal common cancer with an estimated 5-year survival rate of 6–7% (across all stages). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
351
-
352
-
353por Bimonte, Sabrina, Barbieri, Antonio, Leongito, Maddalena, Piccirillo, Mauro, Giudice, Aldo, Pivonello, Claudia, de Angelis, Cristina, Granata, Vincenza, Palaia, Raffaele, Izzo, Francesco“…Pancreatic cancer (PC) is one of the deadliest cancers worldwide. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
354“…Pancreatic cancer, mostly pancreatic ductal adenocarcinoma (PDAC), is a leading cause of cancer-related death in the US, with a dismal median survival of 6 months. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
355“…As the mechanisms by which hypoxia signaling impacts invasion and metastasis in pancreatic cancer are being elucidated, hypoxia is emerging as a key determinant of pancreatic cancer malignancy as well as an important target for therapy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
356por Peng, Yun-Peng, Zhu, Yi, Yin, Ling-Di, Zhang, Jing-Jing, Guo, Song, Fu, Yue, Miao, Yi, Wei, Ji-Shu“…However, the expression of MCMs in pancreatic cancer (PC) was less investigated so far. This study was designed to analyze the expression and prognostic roles of MCM1-10 in PC based on the data provided by The Cancer Genome Atlas (TCGA). …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
357“…The prognosis of pancreatic cancer is extremely poor compared to other cancers. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
358“…This bibliometric analysis aimed to explore the top classic citations in pancreatic cancer (PC) research. METHODS: A computerized literature search was conducted using the database, the Science Citation Index Expanded. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
359“…Despite the important improvements made in the fields of surgery, chemotherapy and radiation therapy, pancreatic cancer remains one of the most lethal malignancies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
360por Hardie, Rae-Anne, van Dam, Ellen, Cowley, Mark, Han, Ting-Li, Balaban, Seher, Pajic, Marina, Pinese, Mark, Iconomou, Mary, Shearer, Robert F., McKenna, Jessie, Miller, David, Waddell, Nicola, Pearson, John V., Grimmond, Sean M., Sazanov, Leonid, Biankin, Andrew V., Villas-Boas, Silas, Hoy, Andrew J., Turner, Nigel, Saunders, Darren N.“…BACKGROUND: Pancreatic cancer has a five-year survival rate of ~8%, with characteristic molecular heterogeneity and restricted treatment options. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto